Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Hypogonadism
Interventions
DRUG

NEBIDO

Patients will receive 54 weeks of treatment with Nebido, 5 intramuscular injections of 4ml Nebido (at baseline, week 6, 18, 30, 42)

DRUG

PLACEBO

Patients will receive 54 weeks of treatment with placebo, 5 intramuscular injections of 4ml placebo (at baseline, week 6, 18, 30, 42)

Trial Locations (25)

20132

Milan

53105

Bonn

80131

Napoli

117036

Moscow

123367

Moscow

197022

Saint Petersburg

400138

Volgograd

630091

Novosibirsk

06097

Halle

00155

Roma

LV-1002

Riga

91-425

Lodz

01-432

Warsaw

01-809

Warsaw

02-777

Warsaw

50-088

Wroclaw

RG2 7AG

Reading

NW3 2QG

London

NW9 9NH

London

M15 6SX

Manchester

WS14 9JL

Lichfield

G81 2DR

Glasgow

B15 2SQ

Birmingham

CF14 5GJ

Cardiff

PR7 7NA

Chorley

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY